MannKind Corp at RBC Capital Markets Global Healthcare Conference Transcript
(technical difficulty) back to the 2022 RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotechnology equity research analysts here at RBC. And we're pleased to be joined by MannKind today. And joining us is the CEO, Michael Castagna. Michael, thanks so much for joining us. Great to see you and be in person.
Great to meet you in person.
Questions & Answers
Yes, it's the first time, and a lot of virtual, but now is the time to get back to some degree of normalcy. And with that, for those of us who aren't familiar with MannKind, maybe, Mike, we can just start with having you give us a brief introduction to the Company. But also, I think particularly relevant is an announcement today on a deal that you and the team have conducted, so that maybe we could also hear a little bit about that and what you took in this morning.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |